Newsletter No. 91 -- March 2007
NIH - New Funding Initiatives
1. ACADEMIC-INDUSTRIAL PARTNERSHIPS FOR DEVELOPMENT AND VALIDATION OF IN VIVO IMAGING SYSTEMS AND METHODS FOR CANCER INVESTIGATIONS (R01) (NCI) (PAR-07-214)
Application Receipt Date(s): Standard dates apply
The goal is to accelerate the transition of in vivo spectroscopic and imaging systems and methods into cancer research, clinical trials, and/or clinical practice. A related goal is to advance new technologies and methods for animal imaging. The Cancer Imaging Program (CIP) of the National Cancer Institute (NCI) solicits applications from multi-institutional research partnerships formed by academic, industrial, and other investigators, for the purpose of developing imaging technology that is applicable to cancer research involving human subjects and/or animal models. The academic-industrial partnerships must be dedicated to the complete research and development cycle, culminating in the product prototype stage. The partnership model is expected to more readily overcome various barriers to the development of new imaging devices and technologies faced by either academia or industry working alone.
2. NIH PATHWAY TO INDEPENDENCE (PI) AWARD (K99/R00) (NIH) (PA-07-297)
Application Receipt Date(s): Standard dates
NIH believes that the creativity and innovation of new independent investigators in their early career stages play an integral role in addressing our Nation's biomedical, behavioral, and clinical research needs. The intent of the Pathway to Independence Program is to assist new investigators in transitioning to stable independent research positions at an earlier age and with an enhanced probability of success in obtaining independent NIH or other independent research support. The PI award will provide up to 5 years of support consisting of two phases. The initial mentored phase will provide support for up to 2 years for the most promising and exceptionally talented new investigators who have no more than 5 years of postdoctoral research training experience at the time of initial application or subsequent resubmission(s). This initial phase of mentored support will allow the candidate time to obtain additional training, complete research, publish results, and bridge to an independent research position. The candidate must propose a research project that will be pursued during the K99 phase and transition into an independent project during the R00 phase of the award. The candidate and mentor(s) together will be responsible for all aspects of the mentored (K99 phase) career development and research program.
URL for IC-specific information: http://grants.nih.gov/grants/guide/contacts/pa-07-297_contacts.htm
URL for Pathway to Independence FAQs: http://grants1.nih.gov/grants/new_investigators/QsandAs.htm
3. CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE (R01) (Multiple ICs) (PAR-07-235)
Application Receipt Date(s): May 17, 2007 and September 13, 2007 Peer Review Date(s): October, 2007 and February, 2008
Biomedical research laboratories increasingly undertake a software development project to solve a problem of interest to that laboratory. These software packages sometimes become useful to a much broader community of users that can include translational and clinical researchers. The goal of this program announcement is to support the continued development, maintenance, testing and evaluation of existing software. The proposed work should apply best practices and proven methods for software design, construction, and implementation to extend the applicability of existing biomedical informatics/computational biology software to a broader biomedical research community.
4. BIOENGINEERING RESEARCH GRANTS (BRG)(R01) (multiple ICs) (PA-07-279)
Application Receipt Date(s): Standards dates apply
Participating ICs invite applications for R01 awards to support Bioengineering Research Grants (BRGs) for basic and applied multi-disciplinary research that addresses important biological, bioengineering or medical research problems. The BRGs support multi-disciplinary research performed in a single laboratory or by a small number of investigators that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research.
5. COMPREHENSIVE MINORITY INSTITUTION/CANCER CENTER PARTNERSHIP (U54) (NCI) (RFA-CA-07-045)
Application Receipt Date(s): April 13, 2007
The NCI invites cooperative agreement (U54) linked award applications for the implementation of Comprehensive Minority Institution/Cancer Center Partnerships (MI/CCPs) between Minority-Serving Institutions (MSIs) and NCI-designated Cancer Centers (or groups of Centers). The purpose of this funding opportunity announcement is to foster and support intensive collaborations among MSIs and the cancer centers in order to develop stronger national cancer programs aimed at understanding the reasons behind the significant cancer disparities and related impacts on racial and ethnic minority and socio-economically disadvantaged populations.
6. PHS 2007-02 OMNIBUS SOLICITATION OF THE NIH FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44]) AND TECHNOLOGY TRANSFER GRANT APPLICATIONS (PARENT STTR [R41/R42])
Application dates: April 5, 2007; August 5, 2007; December 5, 2007
URL for SBIR: http://grants.nih.gov/grants/guide/pa-files/PA-07-280.html
URL for STTR: http://grants.nih.gov/grants/guide/pa-files/PA-07-281.html
NOTICE OF INTENT TO PUBLISH A REQUEST FOR APPLICATIONS FOR THE NIH DIRECTOR'S NEW INNOVATOR AWARDS (ROADMAP) (NOT-OD-07-047)
The Office of the Director, NIH, plans to issue an RFA in the spring of 2007, with review and funding expected by September 30, 2007, for NIH Director's New Innovator Awards. This new program extends the concept of the NIH Director's Pioneer Awards (http://nihroadmap.nih.gov/pioneer/) to support new investigators of exceptional creativity who propose innovative approaches that have the potential to produce an unusually high impact on significant problems in biomedical and behavioral research. The NIH Director's New Innovator Awards will provide grant support to highly innovative new investigators who have not yet obtained a traditional R01 grant. Applicants must hold an independent research position at a domestic institution, and be within 10 years of their terminal degree (l997 or later).
THE AMERICAN COLLEGE OF RADIOLOGY IMAGING NETWORK (ACRIN) (LIMITED COMPETITION U01) (NCI) (RFA-CA-07-505)
Application Receipt Date: April 10, 2007
EXTENSION OF NIH PILOT STUDY TO SHORTEN THE REVIEW CYCLE FOR NEW INVESTIGATOR R01 APPLICATIONS (CSR) (NOT-OD-07-034)
As part of the National Institutes of Health continuing commitment to new investigators, a pilot effort was begun in 2006 to allow new investigators to have the option of submitting a resubmission/amended R01 application for consecutive review cycles, saving four months. The two cycles of the pilot have involved over 1100 R01 applications reviewed in 40 study sections in the Center for Scientific Review. Approximately 15% of the eligible new investigators have used the option of next cycle submission. The Center for Scientific Review is committed to continuing this pilot for the current study sections and to the extension to all new investigator R01 applications by the end of 2007.
SELECTION OF APPROPRIATE FUNDING OPPORTUNITY ANNOUNCEMENTS (FOAS) FOR THE CONTINUATION OF THE INNOVATIVE TECHNOLOGIES FOR MOLECULAR ANALYSIS OF CANCER (IMAT) PROGRAM (NCI) (NOT-CA-07-005)
The NCI-sponsored Innovative Technologies for Molecular Analysis of Cancer (IMAT) Program, which is aimed at the development and integration of novel and emerging technologies in the support of cancer research, diagnosis, and treatment, now encompasses an array of 12 closely-related Funding Opportunity Announcements (FOAs). This Notice is designed to help potential IMAT applicants identify appropriate FOAs. Note that NONE of these is to be used for research emphasizing imaging technologies.
NHLBI CREATES A NEW CLINICAL RESEARCH GUIDE (NHLBI) (NOT-HL-07-002)
The NHLBI has created a new website which combines policies and procedures with practical guidance on grant application, review, funding and oversight. This is an excellent resource for the "new investigator" and provides easy access to specific information for the more experienced investigator. Please take a moment to visit the site and to share it with colleagues who may find it useful.
URL for NHLBI Clinical Research Guide: http://www.nhlbi.nih.gov/crg/index.php
EXTENSION OF SEVERAL NRSA TRAINING (T), NRSA FELLOWSHIP (F), AND CAREER DEVELOPMENT (K) FUNDING OPPORTUNITY ANNOUNCEMENTS (NIH) (NOT-OD-07-043)
The Ruth L. Kirschstein National Research Service Award (NRSA) Institutional training grant (T), NRSA Fellowship (F) and Career Development (K) Funding Opportunity Announcement s (FOAs) listed below have expiration dates prior to the anticipated conversion of these programs to electronic submission. However, the date of conversion of the T, F, and K mechanisms has been delayed. Due to the upcoming receipt dates for several FOAs using these mechanisms, their expiration dates are being extended until January 3, 2008.
Stanford Molecular Imaging Scholars Program
Postdoctoral Training in Molecular Imaging of Cancer, Stanford University, Stanford, CA, USA
Application deadline: May 14, 2007
The Stanford Molecular Imaging Scholars (SMIS) Program is a diverse training program bringing together more than thirteen Departments, predominantly from the Stanford Schools of Medicine and Engineering, in order to train the next generation of interdisciplinary leaders in molecular imaging.
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
NIH Regional Seminars on Program Funding and Grants
The OER will conduct a seminar in Research Triangle Park, NC, April 24-26, sponsored by several local higher education and research institutions. Pre-registration for the seminars is available now.
17th International Symposium on Radiopharmaceutical Sciences
April 30 - May 4, 2007, Aachen, Germany
International Symposium on Ultrasonic Imaging and Tissue Characterization
May 16-18, 2007, Holiday Inn/Rosslyn Westpark Hotel, Arlington, Virginia
ISMRM 15th Scientific Meeting and Exhibition
May 19 - 25, 2007, Berlin, Germany
Society of Nuclear Medicine 54th Annual Scientific Meeting
June 2 - 6, 2007, Washington, DC
Society for Imaging Informatics in Medicine (SIIM)
June 7-10, 2007, Providence, RI
Frontiers of Biomedical Imaging Science
June 27-29 2007,Nashville, Tennessee
CARS 2007 Computer Assisted Radiology and Surgery -21st International Congress and Exhibition
June 27 - 30, 2007, Bonn, Germany
American Association of Physicists in Medicine (AAPM) - 49th Annual Meeting
July 22-26, 2007, Minneapolis, MN
Molecular Imaging Joint Conference of the Academy of Molecular Imaging and the Society for Molecular Imaging
September 7 - 11, 2007, Providence, Rhode Island
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (email@example.com). Please include your complete mailing address, title, phone and fax numbers. Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI 6130 Executive Boulevard - MSC-7412 Bethesda, MD 20892-7412 Tel: 301 496 9531 Fax: 301 480 3507